Access to and use of $4 generic programs in Medicare
- PMID: 22311333
- PMCID: PMC3445678
- DOI: 10.1007/s11606-012-1993-9
Access to and use of $4 generic programs in Medicare
Abstract
Background: Although four-dollar programs ($4 per 30-day supply for selected generic drugs) have become important options for seniors to obtain affordable medications, little is known about access to these programs and the characteristics of those who use them.
Objectives: We quantify access to $4 programs based on driving distance; evaluate factors affecting the program use and potential cost-savings associated with switching to $4 programs in Medicare.
Design: Observational study.
Setting: US Medicare Part D data, 5% random sample, 2007
Participants: 347,653 elderly beneficiaries without Medicaid coverage or low-income subsidies.
Main measures: We evaluated how use of $4 programs was affected by driving distance to the store and the beneficiary's demographic and socioeconomic status, insurance coverage, health status, comorbidities, and medication use. For those who did not use the $4 programs, we calculated potential savings from switching to $4 generics.
Key results: Eighty percent of seniors in Medicare Part D filled prescriptions for generic drugs that were commonly available at $4 programs. Among them, only 16.3% filled drugs through $4 programs. Beneficiaries who lived in poor areas, had less insurance, more co-morbidities, and used more drugs and lived closer to $4 generic retail pharmacies, were more likely to use these programs. Blacks were less likely to use the program relative to Whites (15.0% vs. 16.4%; OR=0.75, 95% CI 0.71-0.80). While 53.2% of nonusers would save by switching to $4 program after incorporating travelling costs, 58% of those who could save would have net annual out-of-pocket savings of less than $20.
Conclusions: The take-up rate of $4 programs was low in 2007 among Medicare beneficiaries. As more stores offer $4 programs and increasing numbers of drugs become generic, more beneficiaries could potentially benefit, as could the Medicare program.
Figures
Similar articles
-
Low-Cost Generic Program Use by Medicare Beneficiaries: Implications for Medication Exposure Misclassification in Administrative Claims Data.J Manag Care Spec Pharm. 2016 Jun;22(6):741-51. doi: 10.18553/jmcp.2016.22.6.741. J Manag Care Spec Pharm. 2016. PMID: 27231801 Free PMC article.
-
A comparison of costs of Medicare Part D prescriptions dispensed at retail and mail order pharmacies.J Manag Care Spec Pharm. 2014 Sep;20(9):959-67. doi: 10.18553/jmcp.2014.20.9.959. J Manag Care Spec Pharm. 2014. PMID: 25166295 Free PMC article.
-
Impact of cost sharing on prescription drugs used by Medicare beneficiaries.Res Social Adm Pharm. 2010 Jun;6(2):100-9. doi: 10.1016/j.sapharm.2010.03.003. Epub 2010 May 7. Res Social Adm Pharm. 2010. PMID: 20511109
-
Medicare beneficiaries' out-of-pocket costs for commonly used generic drugs, 2009-2017.Am J Manag Care. 2020 Mar;26(3):112-117. doi: 10.37765/ajmc.2020.42635. Am J Manag Care. 2020. PMID: 32181626
-
Medicare Part D and quality of prescription medication use in older adults.Drugs Aging. 2011 Oct 1;28(10):797-807. doi: 10.2165/11595250-000000000-00000. Drugs Aging. 2011. PMID: 21970307 Free PMC article. Review.
Cited by
-
Use and Cost Patterns of Antihypertensive Medications in the United States From 1996 to 2021.Hypertension. 2024 Nov;81(11):2307-2317. doi: 10.1161/HYPERTENSIONAHA.124.23509. Epub 2024 Sep 4. Hypertension. 2024. PMID: 39229724
-
Underprescribing vs underfilling to oral anticoagulation: An analysis of linked medical record and claims data for a nationwide sample of patients with atrial fibrillation.J Manag Care Spec Pharm. 2022 Dec;28(12):1400-1409. doi: 10.18553/jmcp.2022.28.12.1400. J Manag Care Spec Pharm. 2022. PMID: 36427343 Free PMC article.
-
Association Between Cost-Saving Prescription Policy Changes and Adherence to Chronic Disease Medications: an Observational Study.J Gen Intern Med. 2022 Feb;37(3):531-538. doi: 10.1007/s11606-021-07031-w. Epub 2021 Jul 30. J Gen Intern Med. 2022. PMID: 34331213 Free PMC article.
-
Assessment of Second-Generation Diabetes Medication Initiation Among Medicare Enrollees From 2007 to 2015.JAMA Netw Open. 2020 May 1;3(5):e205411. doi: 10.1001/jamanetworkopen.2020.5411. JAMA Netw Open. 2020. PMID: 32442290 Free PMC article.
-
Adherence to treatment and related factors among patients with chronic conditions in primary care: a cross-sectional study.BMC Fam Pract. 2019 Sep 14;20(1):132. doi: 10.1186/s12875-019-1019-3. BMC Fam Pract. 2019. PMID: 31521114 Free PMC article.
References
-
- Wal-Mart Stores Inc. Affordable prescription program. http://walmartstores.com/healthwellness/8247.aspx. Accessed May 4, 2011.
-
- Target.com. Target 4 dollar listing. http://sites.target.com/site/en/health/page.jsp?contentId=PRD03-004319. Accessed January 10, 2010.
-
- Kaiser Family Foundation. Prescription Drug Trends. http://kff.org/rxdrugs/3057.cfm. Accessed February 18, 2010.
-
- Kaiser Family Foundation. Medicare prescription drug plans in 2010 and key changes over five years: summary of findings. 2010; http://www.kff.org/medicare/upload/8096.pdf. Accessed September 1, 2011.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
